Research and Innovation
Using estrogen to treat breast cancer
In this video, Gary N. Schwartz, MD, and Todd Miller, PhD explain one of several breast cancer clinical trials they are leading.
Helping to prevent colorectal cancer with machine learning
Dartmouth Cancer Center research introduces new technology that helps pathologists more accurately classify polyps.
Dartmouth Cancer Center expands program that provides protected research time for clinician-scientists
Dartmouth Health has renewed its successful Cancer Faculty Fellows program. More than $1M annually to be distributed to selected oncology clinicians will allow them up to 2 days a week for dedicated cancer research.
Precision cancer prevention research and innovation
Precision prevention means developing tools to map each person’s individual risk factors for cancer, and creating bold new strategies to reduce those risks.
Treating Deadly Breast Cancer with a Plant Virus-based Immunotherapy
Newly patented plant virus-based immunotherapy could bring new options for inflammatory breast cancer patients.
Landmark Advancements in Radiation Oncology Technology
Researchers and clinicians synergize basic research with commercial entrepreneurship to open new doors in the field of radiation oncology.
Precision Cancer Prevention at Dartmouth Cancer Center
Hear from an expert medical panel about groundbreaking developments happening around precision prevention and cancer care at Dartmouth Cancer Center.
Next-Generation Immunotherapy at Dartmouth Cancer Center
For 50 years, doctors and scientists at Dartmouth Cancer Center have been expanding the boundaries of cancer care, including breakthroughs in immunotherapy, that use the body’s own immune system to combat cancer.
Where Do Prouty Donations Go? The 40th Annual Prouty in Action
The record-breaking $4M raised by the 40th annual Prouty helps cancer researchers break ground on what will become the latest scientific advancements in cancer.
New Detailed Immune-profiling Method Uses Only DNA from Blood
A new immune-profiling method could support personalized prediction of outcomes in immunotherapy patients.